郑华, 周雨霏, 廖希一, 李夷民. 不同大体肿瘤体积纵轴外扩长度在食管鳞癌根治性放化疗中的疗效比较[J]. 中国肿瘤临床, 2016, 43(19): 849-854. DOI: 10.3969/j.issn.1000-8179.2016.19.756
引用本文: 郑华, 周雨霏, 廖希一, 李夷民. 不同大体肿瘤体积纵轴外扩长度在食管鳞癌根治性放化疗中的疗效比较[J]. 中国肿瘤临床, 2016, 43(19): 849-854. DOI: 10.3969/j.issn.1000-8179.2016.19.756
Hua ZHENG, Yufei ZHOU, Xiyi LIAO, Yimin LI. Efficacy comparison of different clinical target volume margins in the radical therapy of esophageal squamous cell carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 43(19): 849-854. DOI: 10.3969/j.issn.1000-8179.2016.19.756
Citation: Hua ZHENG, Yufei ZHOU, Xiyi LIAO, Yimin LI. Efficacy comparison of different clinical target volume margins in the radical therapy of esophageal squamous cell carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 43(19): 849-854. DOI: 10.3969/j.issn.1000-8179.2016.19.756

不同大体肿瘤体积纵轴外扩长度在食管鳞癌根治性放化疗中的疗效比较

Efficacy comparison of different clinical target volume margins in the radical therapy of esophageal squamous cell carcinoma

  • 摘要: 目的:比较食管癌选择性淋巴结区域照射(elective node irradiation ,ENI)基础上原发病灶大体靶区纵向外扩不同长度的生存差异,探讨食管鳞癌(esophageal squamous cell cancer,ESCC)临床靶区的优化。方法:回顾性分析2009年5 月至2012年11月厦门大学附属第一医院行放化疗初治的ENI 的ESCC患者。根据大体靶区纵向外扩长度不同分为纵向外扩范围≤ 3 cm组及> 3 cm组,依次命名为临床肿瘤体积1 组(clinical tumor volume of group1,CTV 1)及临床肿瘤体积2 组(clinical tumor volume of group 2,CTV 2),比较不同纵向外扩长度的临床肿瘤体积(clinical tumor volume ,CTV )分组的生存率及不良反应差异。结果:142 例患者纳入研究,其中CTV 1 组81例,CTV 2 组61例,两组生存差异及不良反应的发生率差异均无统计学意义。结论:基于ENI 的ESCC原发病灶纵向外扩3 cm形成的CTV 照射后的生存率不低于GTV 纵向外扩> 3 cm的CTV 照射。建议选择性淋巴结区域照射时GTV纵轴外扩≤ 3 cm。

     

    Abstract: Objective: To compare the therapeutic effects by different longitude margins of the gross tumor volume (GTV) based on elec-tive nodal irradiation (ENI) and to investigate the optimization of clinical tumor volume (CTV) in the radical chemoradiotherapy of esophageal squamous cell carcinoma (ESCC).Methods:ESCC patients treated with chemoradiotherapy for the first time in the First Af -filiated Hospital of Xiamen University from May 2009to November 2012were retrospectively studied. All patients were treated with ENI for radical radiotherapy, and the patients were divided into two groups: CTV1 group (with longitudinal external expansion length of less than 3 cm) and CTV2 group (with longitudinal external expansion length of more than 3 cm). The survival time and occurrence of side effects in patients were compared. Results:Among the 142 cases of patients,82and 61cases were classified under CTV1 and CTV 2, respectively. No significant difference in the overall survival (OS) and local recurrence-free survival (LRFS) rates was observed af -ter 1, 3, and 5 years of treatment between the two groups. The occurrence of side effects, such as bone marrow suppression, radiation pneumonitis, radiation esophagitis, and esophageal fistula, was less than 5% in both groups, and the data show that the side effect oc-currence in CTV 1 was significantly lower.Conclusion: In the radical chemoradiotherapy of esophageal cancer using ENI, the OS rate of patients with a delineated CTV according to a 3 cm GTV longitudinal external expansion length is not lower than that of patients with a delineated CTV according to a GTV longitudinal external expansion length of more than3 cm. The results provide a reference for the optimization of CTV in the radical chemoradiotherapy of ESCC.

     

/

返回文章
返回